CERNER ANNOUNCES QUARTERLY DIVIDEND
March 20 2020 - 9:15AM
Cerner Corporation (Nasdaq: CERN), a global health care technology
company, today announced that its Board of Directors declared a
cash dividend to stockholders of $0.18 per issued and outstanding
share. The cash dividend will be payable on April 17, 2020, to
shareholders of record as of the close of business on April 3,
2020.
Cerner intends to pay regular quarterly cash
dividends, with future declarations subject to approval by its
Board of Directors and their determination that the declaration of
dividends remains in the best interests of Cerner and its
shareholders. The decision of whether to pay future dividends and
the amount of any such dividends will be based on the company's
financial position, results of operations, cash flows, capital
requirements, the requirements of applicable law and any other
factors the Board of Directors may deem relevant.
About CernerCerner’s health
technologies connect people and information systems at thousands of
contracted provider facilities worldwide dedicated to creating
smarter and better care for individuals and communities. Recognized
globally for innovation, Cerner assists clinicians in making care
decisions and assists organizations in managing the health of their
populations. The company also offers an integrated clinical and
financial system to help manage day-to-day revenue functions, as
well as a wide range of services to support clinical, financial and
operational needs, focused on people. For more information, visit
Cerner.com, The Cerner Blog, The Cerner Podcast or connect on
Facebook, Instagram, LinkedIn or Twitter. Nasdaq:
CERN. Health care is too important to stay the
same.
All statements in this press release that do not
directly and exclusively relate to historical facts constitute
forward-looking statements. These forward-looking statements are
based on the current beliefs, expectations and assumptions of
Cerner's management with respect to future events and are subject
to a number of significant risks and uncertainties. It is important
to note that Cerner's performance, and actual results, financial
condition or business could differ materially from those expressed
in such forward- looking statements. The words “” intends,”
‘future,” or the negative of these words, variations thereof or
similar expressions are intended to identify such forward-looking
statements. For example, our forward-looking statements include
statements regarding future dividends. Factors that could cause or
contribute to such differences include, but are not limited to the
possibility of significant costs and reputational harm related to
product and service-related liabilities; potential claims for
system errors and warranties; the possibility of interruption at
our data centers or client support facilities, or those of third
parties with whom we have contracted (such as public cloud
providers), that could expose us to significant costs and
reputational harm; the possibility of increased expenses, exposure
to legal claims and regulatory actions and reputational harm
associated with a cyberattack or other breach in our IT security or
the IT security of third parties on which we rely; material adverse
resolution of legal proceedings or other claims or reputational
harm stemming from negative publicity related to such claims or
legal proceedings; risks associated with our global operations,
including without limitation greater difficulty in collecting
accounts receivable or pandemics and public health problems, such
as the outbreak of novel coronavirus (COVID-19); risks associated
with fluctuations in foreign currency exchange rates; changes in
tax laws, regulations or guidance that could adversely affect our
tax position and/or challenges to our tax positions in the U.S. and
non-U.S. countries; risks associated with the unexpected loss or
recruitment and retention of key personnel or the failure to
successfully develop and execute succession planning to assure
transitions of key associates and their knowledge, relationships
and expertise; risks related to our dependence on strategic
relationships and third party suppliers, including any impact
thereon resulting from events such as the coronavirus; risks
inherent with business acquisitions or strategic investments and
the failure to achieve projected synergies; risks associated with
volatility and disruption resulting from global economic or market
conditions, including any impact thereon resulting from events such
as the coronavirus; significant competition and our ability to
anticipate or respond quickly to market changes, changing
technologies and evolving pricing and deployment methods and to
bring competitive new solutions, devices, features and services to
market in a timely fashion; managing growth in the new markets in
which we offer solutions, health care devices or services; long
sales cycles for our solutions and services; risks inherent in
contracting with government clients, including without limitation,
complying with strict compliance and disclosure obligations,
navigating complex procurement rules and processes, and defending
against bid protests; risks associated with our outstanding and
future indebtedness, such as compliance with restrictive covenants,
which may limit our flexibility to operate our business; the
potential for losses resulting from asset impairment charges;
changing political, economic, regulatory and judicial influences,
which could impact the purchasing practices and operations of our
clients and increase costs to deliver compliant solutions and
services; non-compliance with laws, government regulation or
certain industry initiatives or failure to deliver solutions or
services that enable our clients to comply with laws or regulations
applicable to their businesses; variations in our quarterly
operating results; potential variations in our sales forecasts
compared to actual sales; volatility in the trading price of our
common stock and the timing and volume of market activity;
inability to achieve expected operating efficiencies and sustain or
improve operating expense reductions; risks that Cerner’s revenue
growth may be lower than anticipated and/or that the mix of revenue
shifts to low margin revenue; and risk that our capital allocation
strategy will not be fully implemented or enhance long-term
shareholder value. Additional discussion of these and other risks,
uncertainties and factors affecting Cerner's business is contained
in Cerner's filings with the Securities and Exchange Commission.
The reader should not place undue reliance on forward-looking
statements, since the statements speak only as of the date that
they are made. Except as required by law, Cerner undertakes no
obligation to update or revise forward-looking statements to
reflect changed assumptions, the occurrence of unanticipated
events, or changes in our business, results of operations or
financial condition over time.
Investor Contact: Allan Kells,
(816) 201-2445,akells@cerner.comMedia Contact:
Misti Preston, (816)
299-2037, MediaRelations@cerner.com
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Sep 2023 to Sep 2024